New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

Dr. Reddy’s Shuts Down Plants Amid Potential Cyberattack

The Indian drugmaker detected a potential breach, and proactively shut down plants.

As Big Pharma races to create a vaccine for COVID-19, they’re susceptible to data breaches that could compromise intellectual property. A recent FiercePharma article discussed a recent event that led to the shutting down of multiple plants to contain the issue. As a preventative measure, Indian generics manufacturer Dr. Reddy’s Laboratories isolated all data center services after they detected a breach. The company has shut down “key” plants in the U.S., U.K., Brazil, India, and Russia. Dr. Reddy’s noted that they do not anticipate any major disruptions to operations due to the incident. 

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub